Immunoglobulin light chain allelic inclusion in systemic lupus erythematosus by Fraser, LD et al.
Eur. J. Immunol. 2015. 00: 1–11 Clinical immunologyDOI: 10.1002/eji.201545599 1
Immunoglobulin light chain allelic inclusion
in systemic lupus erythematosus
Louise D. Fraser∗1, Yuan Zhao∗1, Pamela M. K. Lutalo1, David P. D’Cruz2,
John Cason1, Joselli S. Silva1, Deborah K. Dunn-Walters1, Saba Nayar1,
Andrew P. Cope∗∗3 and Jo Spencer∗∗1
1 Programme in Infection and Immunobiology, King’s College London, London, UK
2 Louise Coote Lupus Unit Guy’s and St Thomas’ NHS Trust, London, UK
3 Academic Department of Rheumatology, King’s College London, London, UK
The principles of allelic exclusion state that each B cell expresses a single light and
heavy chain pair. Here, we show that B cells with both kappa and lambda light chains
(Igκ and Igλ) are enriched in some patients with the systemic autoimmune disease sys-
temic lupus erythematosus (SLE), but not in the systemic autoimmune disease control
granulomatosis with polyangiitis. Detection of dual Igκ and Igλ expression by flow cytom-
etry could not be abolished by acid washing or by DNAse treatment to remove any bound
polyclonal antibody or complexes, and was retained after two days in culture. Both sur-
face and intracytoplasmic dual light chain expression was evident by flow cytometry and
confocal microscopy. We observed reduced frequency of rearrangements of the kappa-
deleting element (KDE) in SLE and an inverse correlation between the frequency of KDE
rearrangement and the frequency of dual light chain expressing B cells. We propose that
dual expression of Igκ and Igλ by a single B cell may occur in some patients with SLE
when this may be a consequence of reduced activity of the KDE.
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 Additional supporting information may be found in the online version of this article at thepublisher’s web-site
Introduction
Functional B-cell receptors are generated by a hierarchical series of
Ig gene rearrangement events initiated during B-cell development
in the bone marrow [1–3]. Following successful IgH rearrange-
ment the IgL genes rearrange starting with the kappa IgL (Igκ)
locus. If one allele of Igκ rearranges in the correct genetic read-
ing frame and can successfully pair with the productively rear-
ranged heavy chain, Igκ protein is expressed with IgH on the
cell surface. If rearrangement at both Igκ alleles is unsuccessful,
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rearrangement of the IgL lambda (Igλ) locus is initiated. If
a B-cell achieves successful rearrangement of IgH and Igκ
or Igλ, the B cell is then exposed to cellular and molecu-
lar processes that regulate central tolerance in the B-cell sys-
tem. This can be achieved by further gene rearrangements,
either de novo or by editing existing light chain rearrangements
[4–8].
Most B cells released into the circulation from the bonemarrow
contain multiple Ig light chain gene rearrangements as a conse-
quence of possible sequential rearrangements of the Igκ alleles,
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and in some cells an additional one or two rearrangements at the
Igλ locus. Moreover, approximately 30% of B cells with functional
Igλ rearrangements also have potentially functional Igκ rearrange-
ments that are in the correct genetic reading frame with no stop
codons [9]. Therefore the inactivation of unwanted rearranged
Igκ, in particular those that are potentially functional and could
be expressed, is an essential mechanism for maintenance of allelic
and isotypic exclusion at the light chain loci in healthy individ-
uals. Inactivation or deletion of unwanted Igκ rearrangements is
achieved by rearrangement of the kappa deleting element (KDE),
located downstream of the IgκC. KDE rearranges by RAG protein-
mediated recombination to either an intronic recombination signal
sequence (iRSS) between the most 3’ IgκJ segment and IgκC, or
to an upstream unrearranged IgκV segment [10–13]. If KDE rear-
ranges to an upstream IgκV the unwanted VJ rearrangement is
deleted, but in most cases KDE rearranges to the iRSS and the
unwanted VJ rearrangement remains intact. In either case, KDE
rearrangement deletes IgκC and the intronic enhancer [10–13].
The mechanisms described above maintain allelic exclusion, so
that despite the potential presence of multiple IgL rearrangements
in a B cell, only a single IgH and IgL pair are expressed. Models
of allelic inclusion in mouse B cells have been described where
two light chains are expressed simultaneously [14]. This may be
associatedwith an autoimmune phenotype, though not necessarily
with autoreactivity [15–18]. Failure of KDE rearrangement can
associate with dual expression of Igk and Igλ by human B cells; a
feature that has been identified in a small percentage of cells in
healthy adults [19–22]
We have studied light chain expression by B cells from patients
with systemic lupus erythematosus (SLE) and healthy controls.
SLE is a chronic autoimmune disease characterised by polyclonal
B-cell hyperactivity and the production of pathogenic autoantibod-
ies targeting self-DNA and nucleoproteins [23–26]. We demon-
strate that B cells from patients with SLE may express Igκ and
Igλ simultaneously, that this is rare in healthy controls or patients
with another systemic autoimmune disease granulomatosis with
polyangiitis (GPA), and we provide evidence suggesting that light
chain allelic inclusion can be a consequence of deficient KDE rear-
rangement in SLE.
Results
Immunoglobulin light chain allelic inclusion by B cells
Peripheral blood B cells from patients with SLE, patients with GPA
and healthy controls were evaluated for their expression of Igκ
and Igλ light chains by flow cytometry. While the vast majority
of B cells from healthy donors and patients with GPA expressed
either Igκ or Igλ but not both (Fig. 1 A–C), approximately 54%
patients with SLE had populations of CD19+ B cells that stained
positive for both Igκ and Igλ light chains (Fig. 1D). Where patients
had frequencies of Igκ and Igλ dual expressing B cells above the
range observed in normal blood or GPA, the average value was
approximately 28%, with a maximum value of over 90%. Dual Igκ
and Igλ expressing B cells were particularly enriched in patients
with lupus nephritis (Fig. 1E). Allelic inclusion was not associated
with autoantibody titres, or disease activity in SLE (Supporting
Information Fig. 1).
Expression of light chains by single cells was investigated by
PCR. B cells from healthy individuals were sorted for expression
of either Igκ or Igλ, and cDNA from each cell was tested in PCR
reactions for amplification of Igκ or Igλ rearrangements. The PCR
efficiency for amplification of light chain genes that agreed with
surface light chain expression was approximately 41%. No exam-
ples of wells with both Igκ+ and Igλ+ PCR amplicons, or ampli-
fication of the ‘wrong’ light chain were obtained from 288 single
Igκ+ or Igλ+ B cells from healthy donors. An example of amplicons
from seven consecutive wells following amplification of Igκ from
Igκ or Igλ expressing B cells from a healthy donor is illustrated
in Fig. 1F. SLE B cells expressing both Igκ+ and Igλ+ were placed
at 1 cell per well in 384 wells of 96-well PCR plates. Of these,
14 wells gave PCR amplicons of both Igκ and Igλ. (Fig. 1F), 43
gave amplicons for Igκ only and 61 gave amplicons for Igλ only.
The PCR amplicons of Igκ and Igλ from each of five single cells
illustrated in Fig. 1F were sequenced and were confirmed to be
productively rearranged Igκ and Igλ rearrangements (Fig. 1G).
Experimentally, these were not adjacent reactions. PCR products
were run alongside positive controls with eight dual positive cells
per well to allow direct comparison of band sizes. Although the
PCR efficiency for dual Igκ+ or Igλ+ B cells was low, the frequency
of detection of amplicons for both Igκ and Igλ from a single cell
was significantly greater in dual Igκ and Igλ+ positive cells from
SLE patients than in the single Igκ+ or Igλ+ positive cells in healthy
donors by χ2 analysis (p = 0.001). The reason for PCR inefficiency
for dual Igκ+, Igλ+ positive cells is not clear.
If the presence of both light chains were a consequence of
binding of polyclonal IgG to the B-cell surface, then the heavy
chain of IgG for example would be evident on all double-positive
cells, which it was not (Fig. 2A and B). To investigate whether
dual light chain expression was a feature of a particular B-cell
compartment, we examined the profile of light chain expression
on transitional (TS) B cells (CD19+ IgD+ CD27− CD10hi), mature
naive (MN) B cells (CD19+ IgD+ CD27− CD10−), memory (Mem)
B cells (CD19+ IgD− CD27+ CD10−), and plasmablasts (PB)
(CD19+ CD38hi CD27hi) by flow cytometry. Wherever expression
of both Igκ and Igλ light chains by CD19+ B cells was present, it
was observed in all B cell subsets studied (Fig. 2C).
We considered a range of possible explanations for the pres-
ence of both Igκ and Igλ on B cells, including binding of poly-
clonal Ig to surface receptors. To explore if binding of exogenous
complexes of DNA and anti-DNA antibodies could account for
detection of both Igκ and Igλ light chains on B cells, PBMCs from
SLE patients were incubated with DNase prior to immunostaining.
Dual light chain cell surface expression was still evident (Fig. 3A).
To further eliminate the possibility that the detection of both light
chains on cell populations was a consequence of FcR-mediated
binding of serum immunoglobulin to the B-cell surface, cells were
washed twice in 0.2 M glycine (pH 3.0) or RPMI-1640 media
(pH 2.5) acidic wash buffers to elute such complexes prior to
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Figure 1. Expression of both Igκ and Igλ light chain by CD19+ B cells in SLE. CD19+ cells from healthy donors (n = 26) and SLE patients (n = 56) were
analysed for cell surface expression of Igκ and Igλ by flow cytometry. (A and B) Representative contour plots of isotype controls for cell surface
expression of Igκ and Igλ by CD19+ cells from a healthy donor and a patient with SLE, respectively. (C) Representative contour plot of cell surface
expression of Igκ and Igλ by CD19+ cells in healthy donors showing clear separation of B cells expressing Igκ and Igλ. (D) Four representative
contour plots of highly variable dual Igκ and Igλ expression by CD19+ B cells in patients with SLE. (E) Frequencies of viable CD19+ B cells expressing
both Igκ and Igλ light chains in healthy donors (n = 26) SLE patients (n = 56) and patients with GPA (n = 23). Each dot shows an individual patient,
bars represent averages. (F) Examples of PCR amplification of Igκ gene rearrangements from six consecutive single B cells expressing Igκ and
failure to amplify Igκ gene rearrangements from six consecutive single B cells expressing Igλ from healthy donors. In contrast, samples of eight
cells pooled and five single cells from patient 43 sorted for dual Igκ and Igλ light chain expression gave products for both Igκ and Igλ. These were
not originally consecutive wells; the PCR products were re run in adjacent lanes to compare band sizes. Representative gels of three independent
experiments are shown. We confirmed that the bands from these five single cells were indeed Igκ and Igλ gene rearrangments by sequencing. V
and J pairings for these rearrangments are illustrated in G. Statistical analyses were performed by Mann–Whitney tests assuming nonparametric
distributions *p < 0.05; **p < 0.005; ***p < 0.0001; **** = p < 0.00001.
immunostaining and flow cytometric analysis. This too did not
alter the flow cytometric profile (Fig. 3A).
To determine whether the expression of both Igκ and Igλ was
stable, dual light chain-expressing SLE B cells were isolated by
FACS and cultured with allogeneic CD3+CD4+ T cells and PMA
for two days. Cells remained positive for both light chains after
the activating culture period (Fig. 3B).
The presence of Igκ and Igλ light chains on the cell surface was
not a feature of dying cells and was not a feature of PBMCs other
than the B-cell subsets described (Supporting Information Fig. 2).
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Figure 2. (A) PBMCs from SLE patient 119
were stained for CD19, IgD, IgG, Igκ, and Igλ
and CD19+ B cells expressing single Igκ (
quadrant 1), single Igλ (quadrant 3), or both
Igκ and Igλ ( quadrant 2) were identified by
flow cytometry. (B) Cells in quadrants 1, 2,
and 3 from A were then regated to iden-
tify cells with surface IgD and IgG. (A, B)
One representative plot out of two indepen-
dent experiments is shown. (C) Quantifica-
tion of flow cytometric analysis of the fre-
quency of Igκ and Igλ light chain expres-
sion in different B-cell subsets in SLE; tran-
sitional (TS) B cells (CD19+ IgD+ CD27−
CD10hi), mature naive (MN) B cells (CD19+
IgD+ CD27− CD10lo), memory (Mem) B cells
(CD19+ IgD− CD27+), and plasmablasts (PB)
(CD19+ CD38hi CD27hi). Each dot shows an
individual patient, bars show averages.
Dual positive B cells had both Igκ and Igλ on the cell
surface and in the cytoplasm
PBMCs from patients with SLE known to show allelic inclusion
were stained to detect surface CD19, Igκ, and Igλ. Cells were then
fixed and permeablised and stained for Igκ and Igλ with antibod-
ies conjugated to different fluorochromes. The vast majority of
cells that had both Igκ+ and Igλ+ on the cell surface also had
intracytoplasmic Igκ and Igλ (Fig. 4A, B) by this method.
PBMCs from SLE patients with a high frequency of Igκ and
Igλ+ cells by flow cytometry were spun onto glass slides using
a cytocentrifuge. Cells were then permeablised and stained to
identify Igκ and Igλ. Whereas healthy B cells were consistently
either Igκ+ or Igλ+, lymphocytes with a superimposed distribution
of Igκ and Igλ on the cell surface and in the cytoplasm could
consistently be observed in cases of SLE that expressed both light
chains by flow cytometry (Fig. 4C).
Lower frequency of KDE rearrangement in SLE
inversely correlates with dual light chain expression
Rearrangement of the KDE normally functionally inactivates rear-
rangements of Igκ that are not used by the cell, by deleting
the constant region and the intronic enhancer. Since produc-
tively rearranged but nonexpressed Igκ segments are carried by
approximately 30% of Igλ expressing B cells [9] we considered
the possibility that failure of KDE rearrangement, that has also
been described previously in SLE [29], could permit aberrant
expression of both light chains simultaneously. To ask whether
the expression of both Igκ and Igλ could be the result of a reduced
frequency of rearrangement of the KDE in the patients stud-
ied, iRSS-KDE rearrangements were quantified in the genomic
DNA isolated from FACS-sorted populations of CD19+Igλ+ B cells
from SLE patients and healthy donors by quantitative real-
time PCR (qRT-PCR) (Fig. 5A–C). The frequency of iRSS-KDE
rearrangements in Igλ—expressing B cells in SLE was significantly
lower than observed in healthy donors (Fig. 5C).
To ask whether the reduced frequency of rearrangement of
the KDE to the iRSS observed in SLE compared to healthy donors
was due to more frequent KDE rearrangement to IgκV segments
rather than the iRSS, qRT-PCR primers were designed to target
the IgκJ-IgκC intron, 5’ of the iRSS in the same genomic DNA
samples from which iRSS-KDE rearrangement frequency had been
determined (Fig. 5D). The frequency of KDE rearrangements to
this intronic sequence was equivalent in CD19+ Igλ+ B cells from
healthy donors and patients with SLE (Fig. 5E), indicating that
there was no difference in the frequency of KDE rearrangement to
IgκV segments in healthy donors and SLE. This observation also
provided a control to demonstrate that the reduced frequency
of KDE rearrangements observed in sorted B cells from patients
with SLE in Fig. 5C was not a consequence of inclusion of B cells
expressing Igκ only in the sorted populations of cells since the
same DNA samples were used for both sets of experiments.
To test if there was any association between reduced frequency
of rearrangement of KDE to iRSS in a population of cells and allelic
inclusion in SLE, the frequencies of B cells expressing both Igκ
and Igλ light chains and the relative frequency of rearrangement
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Figure 3. Cell surface expression of Igκ and Igλ light chains following DNAse treatment, acid washes, and cell culture. (A) Flow cytometry analysis
of light chain expression by CD19+ SLE B cells following incubation with DNase, or two acid wash steps using two different acidic wash buffers;
0.2 M glycine (pH3.0) and RPMI-1640 media wash (pH2.5) prior to immunostaining and flow cytometric analysis. Representative contour plots from
three independent experiments with three different donors are shown. (B) Immunoglobulin light chain cell surface expression on sorted Igκ+, Igλ+
CD19+ B cells from an SLE patient was determined by flow cytometry on day 0 or following coculture with allogeneic CD3+CD4+ T cells with PMA
for 2 days. Isotype controls and two replicates (Rep1 and Rep2) out of two independent experiments with two different donors are shown.
of KDE in Igλ expressing B cells in that case were plotted as an
XY graph. We identified an inverse correlation between the fre-
quencies of B cells expressing both Igκ and Igλ light chains and
the frequency of rearrangement of KDE in Igλ expressing B cells,
implying that expression of both light chains is associated with
lower frequency of rearrangement of KDE to iRSS (Fig. 5F).
It was considered possible that reduced KDE rearrangement to
the iRSS but not to IgκV in SLE might be due to differences in the
sequences around the recombination sites or the properties of the
KDE rearrangement itself. Therefore, the junctions and flanking
sequences of rearrangements between the KDE and iRSS were
sequenced following the cloning of PCR-amplified iRSS to KDE
rearrangements from genomic DNA extracted from CD19+ Igλ+
B cells from two healthy controls and two SLE patients with B cells
expressing both light chains. The experiment outline is illustrated
in Fig. 6A. A total of 49 different sequences from healthy controls
and 63 from SLE patients were aligned with the germline sequence
of the intron between IgκJ and IgκC and germline KDE sequence to
identify the breakpoints and to quantify nucleotide additions. No
differences were observed between healthy B cells and SLE B cells
at the intronic RSS and KDE breakpoint or the sequences flanking
them (Fig. 6B). No differences in the frequency of N-nucleotide
additions at the junctions were observed (Fig. 6C).
Discussion
We report that B cells may express both Igκ and Igλ light chains
in some cases of SLE. Light chain isotypic inclusion, that can
affect more than 90% of B cells, was more common in B cells
from SLE patients with more severe disease (as manifest by lupus
nephritis) but was independent of disease activity. In contrast,
dual light chain expression in healthy donors is a relatively rare
event that has been observed previously in healthy subjects with
frequencies of 0.2–2% of B cells [19–22], consistent with our
observations. Light chain isotypic inclusion is not a feature of all
autoimmune diseases, since it was not seen in blood of patients
with GPA.
B cells expressing more than one unique light chain in mice
have been shown to exhibit autoreactivity, and to be present with
relatively high frequency in autoimmune prone mice [14–16].
In mouse models, their frequency also increases with age and
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Figure 4. Dectection of surface and intracellular Igκ and Igλ light chains by CD19+ B cells in SLE. (A) B cells from a patient with SLE gated to identify
B cells with surface Igκ and Igλ, remain Igκ+ and Igλ+ when reanalysed for cytoplasmic Igκ and Igλ. Fluorescence minus one (FMO) controls ae
illustrated. One representative dot plot out of ten independent experiments is shown. (B) This was quantified and found to be consisent in ten
patients previously seen to show dual light chain expression. Intra-DP refers to the percentage of B cells that are double positive for surface Igκ and
Igλ, that are then shown to be Igκ and Igλ following permeabilisation and use of antibodies to Igκ and Igλ conjugated to different fluorochromes.
Bars show the percentage of intracellular double-positive cells out of the total surface double-positive B cells for ten patients analysed. (C) B cells
from healthy controls and SLE patients were stained for Igκ and Igλ expression and analysed by confocal microscopy. Representative images from
two independent experiments with four donors are shown. Original magnification ×60.
autoimmune disease severity. They are present within both plas-
mablast and memory B-cell populations [14–16], and associated
with receptor editing where one light chain rearrangement may
replace another with unwanted specificity [15, 17, 18]. Our data
suggest that these observations in mouse models of SLE are highly
relevant to human disease and that expression of both light chains
simultaneously may contribute significantly to disease pathogen-
esis in the subset of patients affected.
Surprisingly, IgL allelic inclusion associated with autoimmu-
nity or inflammation has not been described in humans previously
despite numerous studies of B cells in SLE. Light chain usage has
been studied at a single cell level by RT-PCR of RNA encoding
IgH and IgL genes [27]. Our analysis suggests that detection of
both light chains by single cell RT-PCR is relatively inefficient and
this could result in failure to detect both expression of both light
chains by PCR alone In addition, if PCR amplicons for two light
chains are obtained from a single B cell in a well, the logical con-
clusion might be to assume that two cells were placed in the well,
and to discard this data. The data obtained by analysis of DNA of
single cells is difficult to interpret. We now know that cells can
carry multiple light chain gene rearrangements even in healthy
B cells [9] and that these are clearly not all used, so analysis of
IgL rearrangements in B cells by PCR of DNA in general may be
difficult to interpret.
Dual light chain expression could represent failure in efficient
receptor editing. The KDE may fail to inactivate the unwanted
rearrangement that has been selected against, so that the new
and the old rearrangements are both retained. Receptor editing is
known to be an important regulator of the maturing B-cell reper-
toire that prevents the survival and maturation of self-reactive
cells [17, 18] and allelic inclusion has been associated with recep-
tor editing [15]. Alternatively the phenotype could represent a
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Figure 5. Relationship between frequency of
KDE rearrangement to the iRSS and dual light
chain expression. (A) Sorting strategy to avoid
biases resulting from gating. Cells express-
ing Igλ were sorted, irrespective of whether
they also expressed Igκ prior to isolation of
genomic DNA. One representative dot plot
out of 34 independent experiments is shown.
(B) Representation of qRT-PCR amplification
of rearrangedKDE/iRSS junctions. (C) Relative
copy numbers (RCN) of iRSS-KDE rearrang-
ments in gDNA isolated from FACS sorted
CD19+ Igλ + B cells from healthy controls
(n = 11) and SLE patients (n = 23) were
determined by qRT-PCR as shown in (B).
RNaseP was used as a reference gene and
data was adjusted in each assay so that cell
line NALM6 had a value of 2. Each dot shows
an individual patient, bars show means. (D)
Representation of qRT-PCR amplification of
intronic sequence between the iRSS and IgKJ.
(E) Relative quantification by qRT-PCR of an
intronic region of the Igκ light chain, located
5’ to the iRSS site, in gDNA isolated from
CD19+ Igλ + B cells from healthy controls
(n = 9) and SLE patients (n = 14) standard-
ised to RNaseP. Each dot shows an individual
patient, bars show means. (F) RCN of iRSS-
KDE rearrangements standardised to RNaseP
is inversely correlated with the frequency of
dual light chain expressing cells. Each dot
shows an individual patient, and regression
line is illustrated. Statistical analysis was
performed by Mann–Whitney tests assuming
nonequal variance (C, E) or Spearman’s test
for correlation (F) where **p < 0.01.
mid-way stage in receptor revision if expression of one light chain
is replaced by expression of another in mature B cells, again by
failure of the KDE to inactivate the unwanted rearrangement [28].
If light chain revision occurs, the exchange of protein on the cell
surface may not mirror the tempo of RNA change that would be
a balance between RNA production at both light chain loci and
extinguishing of activity of the original rearrangement by KDE
rearrangement. This latter possibility could potentially explain the
inefficiency of the single cell PCR. The processes that initiate and
regulate KDE activity and specifically direct the KDE to the iRSS
are not known and it is difficult therefore to speculate as to why
this may be defective in SLE.
The chronic expression of two light chains and the assembly
of IgH with either light chain on the cell surface could increase
the antigen-binding potential of B cells as well as the range of
cognate peptides presented to CD4 T cells as a consequence of a
greater diversity of internalized antigens. It is possible that a single
B-cell receptor could have different specificities on the two arms
so that complex antigenic repertoires might be generated [16].
Dual light chain expressing B cells could differ in their ability to
initiate and escalate pathogenic immune responses. Expression
of both light chains was not associated with a particular B-cell
subset in SLE, but was apparent through the entire spectrum of
B-cell differentiation from transitional B cells through to plas-
mablasts, and thus the aberrant receptors they express could con-
tribute to B-cell responsiveness and function at all points in B-cell
development.
It is interesting that allelic inclusion is associated most closely
with lupus nephritis. It is possible that some of the patients with
SLE classified as not having nephritis but exhibiting high frequen-
cies of dual Igκ− and Igλ−expressing B cells may develop the
disorder in the future. These patients will be followed up to test
if presence of dual Igκ- and Igλ− expressing B cells could be a
prognostic biomarker of more severe disease.
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Figure 6. Comparison of iRSS-KDE junctions and sequences flanking the junctions in B cells from healthy donors and patients with SLE. (A)
KDE rearrangements to the iRSS were PCR amplified from gDNA isolated from CD19+Igλ+ B cells from healthy controls (n = 2) and SLE patients
(n = 2). PCR products were cloned, sequenced, and aligned to germline sequences. (B) Bars show the frequency of sequences that terminate at
specific breakpoints after iRSS-KDE rearrangement. (C) Frequency of N-nucleotide additions to the iRSS-KDE junction in healthy donors (n = 2) and
SLE patients (n = 2) was determined as shown in (A). Bars show percentage of sequences with each number of nucleotide additions to the junction.
In summary, we have demonstrated that B cells in some cases
of SLE can express both Igκ and Igλ simultaneously, and that
this is associated with lower frequency of rearrangement of the
KDE described here and in a previous study [29]. Expression of
multiple B-cell receptor specificities by a single cell could enhance
the potential responsiveness of B cells to antigen and the spectrum
of peptides they can present.
Materials and methods
Patients and peripheral blood samples
Approval for collection of blood samples from SLE patients and
controls for this study was given by the KCL Infectious Dis-
eases BioBank working under the authority of the Southamp-
ton and South West Hampshire Research Ethics Committee (REC
Approval: REC09/H0504/39—-The Control of Inflammation in
Immunity and Autoimmunity; IDB ref JS-1b). All SLE patients ful-
filled the American College of Rheumatology classification criteria
for SLE, with at least four of the 11 criteria present, serially, or
simultaneously [30, 31]. They were all female with average age of
38 years, range 17–73. Information on organ involvement, auto-
antibody titres and disease duration are in Supporting Information
Table 1. GPA patients studied had an average of 54 years (range
27–71) and clinical details are in Supporting Information Table 2.
Antibodies and flow cytometry and confocal
microscopy
PBMCs were isolated from blood or buffy coats by Ficoll–Hypaque
centrifugation for 25 min at 400 g. PBMCs were stained with
CD19−PerCP-Cy5.5, kappa light chain allophycocyanin-H7 (BD
Biosciences Pharmingen) and lambda light chain-Pacific Blue
(Biolegend) and LIVE/DEAD Fixable Aqua (Life Technologies) for
15 min at 4°C before analysis on the FACSCanto (BD Biosciences
Pharmingen) for cell surface expression of CD19, Igκ, and Igλ.
For intracytopasmic staining of light chains, cells were initially
stained as described above, and then permeabilised using Fix-
ation/Permeabilization buffer (eBiosciences) before staining to
detect cytoplasmic Igκ with kappa light chain—AF647 (BioLe-
gend) and Igλ with lambda light chain—AF488 (BioLegend).
Flow cytometric analysis of B-cell subsets involved addi-
tional staining PBMCs with IgD−PE and CD27−PE-Cy7
(BD Biosciences Pharmingen), CD10−allophycocyanin (Biole-
gend), and CD38−PE (eBioscience) where TS B cells
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were defined as CD19+IgD+CD27−CD10hi, MN B cells
as CD19+IgD+CD27−CD10−, memory (Mem) B cells as
CD19+IgD−CD27+ and plasmablasts (PB) as CD19+CD27hiCD28hi
[32]. Data were analysed by FACS Diva. Cells were sorted on the
FACSAria machine (BD Biosciences Pharmingen).
For confocal microscopy, cells were spun onto microscope
slides by cytocentrifuge and fixed and permeabilised with ace-
tone. They were then stained for Igκ with kappa light chain-
–AF647 (BioLegend) and Igλ with lambda light chain—AF488
(BioLegend). Cells were visualized using a Leica DMIRE2 confo-
cal microscope.
Removal of immune complexes and cytophilic binding
of serum Ig
PBMCs were DNase treated (0.1 mg/mL for 30 min at room tem-
perature) before washing and staining for CD19, Igκ, and Igλ.
Acidic wash buffers were made by adjusting a 0.2 M glycine solu-
tion to pH3, and RPMI-1640 medium pH 2.5 with acetic acid.
Total PBMCs were washed twice for 5 min at 1200 rpm before
staining for CD19, Igκ, and Igλ.
Dual expression of Igκ and Igλ after B-cell activation
in culture
CD19+ B cells from an SLE patient with both Igκ and Igλ light
chains on their surface were FACS-sorted and cultured at a
1:1 ratio with sorted allogeneic CD3+CD4+ T cells and PMA
(50 ng/mL). Cells were harvested on day 2 and restained for cell
surface expression of CD19, Igκ, and Igλ.
PCR amplification of rearranged Igκ and Igλ
transcripts from cDNA isolated from single cells
CD19+ B cells expressing both Igκ and Igλ simultaneously were
FACS sorted into 96-well plates containing 18 μL of sort lysis
reverse transcription buffer per well. Following sorting, 2 μL 1:8
SuperScript III (Invitrogen) was added to eachwell prior to reverse
transcription.
Primer sequences are in Supporting Information Table 2. Semi-
nested PCRs were used to detect and amplify V-C transcripts for
both Igκ and Igλ light chain gene rearrangements in the cDNA
of sorted single cells. First round PCR reactions were performed
in a 20 μL volume; 4 μL 5X GC buffer (New England Biolabs),
2 μL 1:20 Phusion DNA polymerase (0.2 U/mL) (New England
Biolabs), 0.2 μL dNTP mix (20 mM each, Promega), 1 μL Vk1-6
or Vl1-8(5’) PCR1 primer mix (835 nM or 1000 nM, respectively),
VkC or VlC (3’) PCR1 primer mix (5 mM each), 1 μL 2.0 M MgCl2,
8.8 μL PCR-grade H20 and 3 μL of cDNA. Second round PCR
reaction was also performed in a 20 μL volume; 4 μL 5X GC
buffer, 2 μL 1:20 Phusion DNA polymerase (0.2 U/mL), 0.2 μL
dNTP mix (20 mM each, Promega), 1 μL Vk1-6 or Vl1-8(5’) PCR2
primer mix (835 nM or 1000 nM, respectively), VkC or VlC (3’)
PCR2 primer mix (5 mM each), 10.8 μL PCR-graded H20 and
2 μL PCR1 product.
PCR cycle conditions for Vk-Ck were as follows; PCR1: 98°C
for 30 s, followed by 50 cycles of 98°C for 10 s, 58°C for 15 s, and
72°C for 40 s. Final extension at 72°C for 10 min. PCR2: 98°C for
30 s, followed by 20 cycles of 98°C for 10 s, 64°C for 15 s, and 72°C
for 15 s. Final extension at 72°C for 10 min. cycle conditions for
Vl-Cl: PCR1: 98°C for 30 s, followed by 50 cycles of 98°C for 10 s,
58°C for 15 s, and 72°C for 30 s. Final extension at 72°C for
10 min. PCR2: 98°C for 30 s, followed by 20 cycles of 98°C
for 10 s, 62°C for 15 s, and 72°C for 15 s. Final extension at 72°C for
10 min.
Quantitative RT-PCR
Quantitative real-time PCR for the amplification of rearranged
iRSS-KDE junctions were designed by Applied Biosystems using a
Taqman Gene Expression Assay. iRSS-KDE rearrangements were
amplified as described by [29]. All qRT-PCRs were performed in
multiplex, with quantification of iRSS-KDE rearrangements stan-
dardised to the Taqman Copy Number Reference Assay, RNaseP,
detected with a VIC-labelled probe (Applied Biosystems). Relative
copy numbers were standardised to the cell line NALM6 that has
two rearrangements of KDE.
Quantitative real-time PCR for the amplification of an
intronic region 5’ to the Jk-Ck intronic RSS were also
produced by Applied Biosystems using a similar Taqman
Gene Expression Assay. This region was amplified with
the following primers 5’-GGGTCTGATGGCCAGTATTGAC-3’ and
5’-CCAATACAATATTTGGCAAG-3’ and were detected with a
FAM-labelled 5’-AAAGATTGGTAAATGAGGGCATTTA-3’ hydroly-
sis probe. This assay was also performed in multiplex qRT-PCR
reaction with the RNaseP reference assay.
Amplification and sequencing of rearranged Igκ genes
and iRSS-KDE rearrangements
DNA was isolated from populations of FACS-sorted CD19+ B cells
using the DNeasy Blood & Tissue Kit (Qiagen). Primer sequences
are shown in Supporting Information Table 2 [25]. First PCR
amplification of IgκV-IgκJ or iRSS-KDE rearrangements was per-
formed under the following cycle conditions: one cycle of 95°C
for 7 min, 56°C for 1 min, and 72°C for 1 min 30 s. Followed
by 30 cycles of 94°C for 1 min, 56°C for 30 s, and 72°C for
1 min 30 s. A final extension of 5 min at 72°C was performed.
Five microliters of each first round PCR product was used in inter-
nal amplifications performed under the following conditions: one
cycle of 95°C for 7 min, 65°C for 1 min, and 72°C for 1 min 30 s.
Followed by 30 cycles of 94°C for 1min, 65°C for 30 s, and 72°C for
1 min 30 s. A final extension of 5 min at 72°C was performed. PCR
products were separated by gel electrophoresis and visualised with
C© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
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ethidium bromide. PCR products were cloned and sequenced as
described previously [28, 33].
Acknowledgments: This work was funded by the Oliver Bird
Rheumatism Programme, the St Thomas’ Wegener’s Trust and the
Medical Research Council UK.We are grateful to LeeMeng Choong
and all of the staff in the Louise Coote Lupus unit and Infectious
diseases biobank for their help consenting patients and collecting
and processing samples for this study.
Conflict of interest: The authors declare no commercial or finan-
cial conflict of interest
References
1 Ehlich, A., Schaal, S., Gu, H., Kitamura, D., Muller, W. and Rajewsky, K.,
Immunoglobulin heavy and light chain genes rearrange independently
at early stages of B cell development. Cell 1993. 72: 695–704.
2 Korsmeyer, S. J., Hieter, P. A., Ravetch, J. V., Poplack, D. G., Waldmann,
T. A. and Leder, P., Developmental hierarchy of immunoglobulin gene
rearrangements in human leukemic pre-B-cells. Proc. Natl. Acad. Sci. USA
1981. 78: 7096–7100.
3 Korsmeyer, S. J., Hieter, P. A., Sharrow, S. O., Goldman, C. K., Leder, P.
andWaldmann, T. A., Normal human B cells display ordered light chain
gene rearrangements and deletions. J. Exp. Med. 1982. 156: 975–985.
4 Melchers, F., ten Boekel, E., Seidl, T., Kong, X. C., Yamagami, T., Onishi,
K., Shimizu, T. et al., Repertoire selection by pre-B-cell receptors and
B-cell receptors, and genetic control of B-cell development from imma-
ture to mature B cells. Immunol. Rev. 2000. 175: 33–46.
5 Hieter, P. A., Korsmeyer, S. J., Waldmann, T. A. and Leder, P., Human
immunoglobulin kappa light-chain genes are deleted or rearranged in
lambda-producing B cells. Nature 1981. 290: 368–372.
6 Radic, M. Z., Erikson, J., Litwin, S. and Weigert, M., B lymphocytes may
escape tolerance by revising their antigen receptors. J. Exp. Med. 1993.
177: 1165–1173.
7 Casellas, R., Shih, T. A., Kleinewietfeld, M., Rakonjac, J., Nemazee, D.,
Rajewsky, K. and Nussenzweig, M. C., Contribution of receptor editing
to the antibody repertoire. Science 2001. 291: 1541–1544.
8 Monestier, M. and Zouali, M., Receptor revision and systemic lupus.
Scand. J. Immunol. 2002. 55: 425–431.
9 Bra¨uninger, A., Goossens, T., Rajewsky, K. and Ku¨ppers R., Regulation
of immunoglobulin light chain gene rearrangements during early B cell
development in the human. Eur. J. Immunol. 2001. 31: 3631–3637.
10 Graninger, W. B., Goldman, P. L., Morton, C. C., O’Brien, S. J. and
Korsmeyer, S. J., The kappa-deleting element. Germline and rearranged,
duplicated and dispersed forms. J. Exp. Med. 1988. 167: 488–501.
11 Klobeck, H. G. and Zachau, H. G., The human CK gene segment and the
kappa deleting element are closely linked. Nucleic Acids Res. 1986. 14:
4591–4603.
12 Siminovitch, K. A., Bakhshi, A., Goldman, P. and Korsmeyer, S. J., A
uniform deleting element mediates the loss of kappa genes in human B
cells. Nature 1985. 316: 260–262.
13 Betz, A. G., Milstein, C., Gonzalez-Fernandez, A., Pannell, R., Larson, T.
and Neuberger, M. S., Elements regulating somatic hypermutation of an
immunoglobulin kappa gene: critical role for the intron enhancer/matrix
attachment region. Cell 1994. 77: 239–248.
14 Fournier, E. M., Velez, M. G., Leahy, K., Swanson, C. L., Rubtsov, A. V.,
Torres, R. M. and Pelanda, R., Dual-reactive B cells are autoreactive and
highly enriched in the plasmablast andmemory B cell subsets of autoim-
mune mice. J. Exp. Med. 2012. 209: 1797–1812.
15 Liu, S., Velez, M. G.,Humann, J., Rowland, S., Conrad, F. J.,Halverson, R.,
Torres R. M. and Pelanda, R., Receptor editing can lead to allelic inclusion
and development of B cells that retain antibodies reacting with high
avidity autoantigens. J. Immunol. 2005. 175: 5067–5076.
16 Makdasi, E. and Eilat, D., L chain allelic inclusion does not increase
autoreactivity in lupus-prone New Zealand Black/New Zealand White
mice. J. Immunol. 2013. 190: 1472–1480.
17 Gay, D., Saunders, T., Camper S. and Weigert, M., Receptor editing: an
approach by autoreactive B cells to escape tolerance. J. Exp. Med. 1993.
177: 999–1008.
18 Tiegs, S. L., Russell D. M. and Nemazee, D., Receptor editing in self-
reactive bone marrow B cells. J. Exp. Med. 1993. 177: 1009–1020.
19 Cuisinier, A. M., Fumoux, F., Fougereau M. and Tonnelle, C., IGM
kappa/lambda EBV human B cell clone: an early step of differentia-
tion of fetal B cells or a distinct B lineage? Mol. Immunol. 1992. 29:
1363–1373.
20 Matsuo, Y., Drexler, H. G., Harashima, A., Takenaka, K., Ishihara,
T., Ishimaru F. and Orita, K., A novel ALL-L3 cell line, BALM-25,
expressing both immunoglobulin light chains. Leuk. Lymphoma. 2004. 45:
575–581.
21 Giachino, C., Padovan, E. and Lanzavecchia, A., kappa+lambda+ dual
receptor B cells are present in the human peripheral repertoire. J. Exp.
Med. 1995. 181: 1245–1250.
22 Pauza, M. E., Rehmann, J. A. and LeBien, T. W., Unusual patterns of
immunoglobulin gene rearrangement and expression during human
B cell ontogeny: human B cells can simultaneously express cell surface
kappa and lambda light chains. J. Exp. Med. 1993. 178: 139–149.
23 Holman, H. R. and Kunkel, H. G., Affinity between the lupus erythemato-
sus serum factor and cell nuclei and nucleoprotein. Science 1957. 126:
162–163.
24 Lipsky, P. E., Systemic lupus erythematosus: an autoimmune disease of
B cell hyperactivity. Nat. Immunol. 2001. 2: 764–766.
25 Kil, L. P. and Hendriks, R. W., Aberrant B cell selection and activation in
systemic lupus erythematosus. Int. Rev. Immunol. 2013. 32: 445–470.
26 Radic, M., Herrmann, M., van der Vlag, J. and Rekvig, O. P., Regulatory
and pathogenetic mechanisms of autoantibodies in SLE. Autoimmunity
2011. 44: 349–356.
27 Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre,
E., Pascual, V. and Nussenzweig, M. C., Defective B cell tolerance
checkpoints in systemic lupus erythematosus. J. Exp. Med. 2005. 201:
703–711.
28 Su, W., Gordon, J. N., Barone, F., Boursier, L., Turnbull, W., Mendis, S.,
Dunn-Walters, D. K. and Spencer, J., Lambda light chain revision in the
human intestinal IgA response. J. Immunol. 2008. 181: 1264–1271.
29 Panigrahi, A. K., Goodman, N. G., Eisenberg, R. A., Rickels, M. R., Naji,
A. and Luning Prak, E. T., RS rearrangement frequency as a marker of
receptor editing in lupus and type 1 diabetes. J. Exp. Med. 2008. 205: 2985–
2994.
C© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
Eur. J. Immunol. 2015. 00: 1–11 Clinical immunology 11
30 Hochberg,M. C., Updating theAmericanCollege of Rheumatology revised
criteria for the classification of systemic lupus erythematosus. Arthritis
Rheum. 1997. 40: 1725.
31 Anolik, J. H., Looney, R. J., Lund, F. E., Randall, T. D. and Sanz, I.,
Insights into the heterogeneity of human B cells: diverse functions, roles
in autoimmunity, and use as therapeutic targets. Immunol. Res. 2009. 45:
144-158
32 Bemark, M., Holmqvist, J., Abrahamsson, J. and Mellgren, K., Transla-
tionalmini-review series on B cell subsets in disease. Reconstitution after
haematopoietic stem cell transplantation—revelation of B cell develop-
mental pathways and lineage phenotypes. Clin. Exp. Immunol. 2012. 167:
15–25.
33 Foster, S. J., Brezinschek, H. P., Brezinschek, R. I. and Lipsky, P.
E., Molecular mechanisms and selective influences that shape the
kappa gene repertoire of IgM+ B cells. J. Clin. Invest. 1997. 99: 1614–
1627.
Abbreviations: GPA: granulomatosis with polyangiitis · Igκ:
immunoglobulin kappa light chain · Igλ: immunoglobulin lambda
light chain · iRSS: intronic recombination signal sequence · KDE:
kappa deleting element · MN: mature naive · SLE: systemic lupus
erythematosus · TS: transitional
Full correspondence: Dr. Jo Spencer, Department of Immunobiology,
King’s College London, Guy’s Campus, St Thomas’ St, London SE1 9RT,
UK
e-mail: jo.spencer@kcl.ac.uk
Fax: 00-44-207-118-3385
Received: 20/2/2015
Revised: 23/4/2015
Accepted: 29/5/2015
Accepted article online: 2/6/2015
C© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
